Who Really Shapes Policy? The Top Lobbying Spenders of 2025 and the Power Behind Them

Handshake in a in a room with people with hidden faces Handshakes behind closed doors change how we as Americans live every day.

Lobbying is often discussed as a background feature of American politics—something abstract, technical, or inevitable. But in practice, lobbying is one of the clearest ways to see whose interests have the most consistent access to lawmakers, regulators, and the policy-writing process itself. Money does not guarantee outcomes, but it determines proximity: who gets meetings, who helps draft language, and whose concerns are treated as “practical realities” rather than political preferences.

In 2025, that reality is difficult to ignore. A small group of organizations spent tens of millions of dollars shaping federal policy across taxes, healthcare, housing, energy, technology, and financial regulation. According to OpenSecrets’ annual ranking of federal lobbying expenditures, five organizations alone accounted for more than $169 million in reported lobbying spending this year.

These are not marginal players. They are institutions that touch nearly every American household—directly or indirectly—through housing costs, drug prices, healthcare access, wages, taxes, and consumer protections.

This article focuses on the five largest lobbying spenders of 2025, not because they are the only influential actors, but because they are the most concentrated expression of a broader system where political influence scales with resources. Many other corporations and trade groups are also deeply involved in lobbying, and they will be cited as well. But to understand how power moves through Washington, it makes sense to begin with the largest spenders and work outward.

All lobbying figures cited below come from OpenSecrets, which tracks disclosures filed under the Lobbying Disclosure Act.
Source: https://www.opensecrets.org/federal-lobbying/top-spenders


The Top Five Lobbying Spenders of 2025

In descending order, the largest lobbying spenders in the United States in 2025 were:

• U.S. Chamber of Commerce — $53,690,000
• National Association of Realtors — $38,431,910
• Pharmaceutical Research & Manufacturers of America (PhRMA) — $29,725,000
• American Hospital Association — $23,877,784
• Business Roundtable — $23,570,000

Together, these organizations represent corporate America, real estate intermediaries, pharmaceutical manufacturers, hospital systems, and Fortune-level CEOs. Each claims to act in the public interest. Each also exists to protect the financial and structural interests of its members.


The U.S. Chamber of Commerce: A Permanent Lobbying Infrastructure for Business

At more than $53 million in 2025, the U.S. Chamber of Commerce once again stands alone as the single largest lobbying spender in Washington.
Source: https://www.opensecrets.org/federal-lobbying/top-spenders

The Chamber is not a company in the conventional sense. It is a political and legal coordination hub for American business, representing industries ranging from finance and energy to technology, retail, and manufacturing. Its influence comes not from a single issue but from its ability to intervene everywhere at once.

Why Spending Is So High in 2025

The Chamber’s elevated spending reflects an unusually dense policy calendar. After years of aggressive rulemaking under the Biden administration, 2025 is a year of implementation, rollback attempts, and high-stakes legislative fights. According to the Chamber’s own policy agenda, its priorities include regulatory “relief,” tax policy, energy permitting, AI governance, financial regulation, and federal spending decisions.

In the first quarter of 2025 alone, the Chamber reported roughly $19.8 million in lobbying expenditures, with the majority flowing through its main entity and additional funds coming from affiliated arms like the Institute for Legal Reform and the Global Innovation Policy Center.
Source: https://www.opensecrets.org/orgs/u-s-chamber-of-commerce/summary?id=D000019798

The issues it targets are not narrow. The Chamber has actively pushed to overturn or weaken regulations issued by agencies such as the Federal Trade Commission and the Consumer Financial Protection Bureau using the Congressional Review Act. It has opposed stricter bank capital requirements, challenged climate-related disclosure rules from the Securities and Exchange Commission, and lobbied on legislation shaping AI governance, data privacy, and cybersecurity frameworks.

Energy policy is another central front. The Chamber has lobbied for faster permitting for fossil fuel and infrastructure projects, protections for LNG exports, favorable treatment of gas-based hydrogen, and limits on environmental regulations affecting PFAS chemicals and emissions.
Source: https://www.reuters.com/world/us/us-chamber-commerce-pushes-back-against-new-regulations-2024-10-12/

What This Means

The Chamber’s role is structural. It allows corporate interests to act collectively rather than individually, multiplying their influence. When nearly every major cost center for business—regulation, taxes, energy, finance, technology—is contested simultaneously, the Chamber becomes the default vehicle through which large firms attempt to shape outcomes.

Handsome senior Caucasian businessman reading document at presentation. His colleagues listening to presentation or working behind him. They sitting in row. Conference concept

National Association of Realtors: Protecting an Asset-Based Housing System

The National Association of Realtors (NAR) spent $38,431,910 on lobbying in 2025.
Source: https://www.opensecrets.org/orgs/national-assn-of-realtors/summary?id=D000000062

NAR’s spending surge did not occur in a vacuum. It followed a period of significant legal and political threat to the real estate industry’s commission structures, market power, and regulatory insulation.

Why NAR Is Spending So Aggressively

In 2024 and 2025, NAR faced landmark antitrust lawsuits challenging traditional broker commissions and MLS practices. At the same time, states and cities began advancing policies such as rent control, vacancy taxes, and higher transfer taxes—measures NAR has consistently opposed.

NAR’s lobbying efforts are aimed at preserving the existing housing transaction model, which treats housing primarily as an asset class rather than a social good. The organization has opposed rent stabilization laws, fought vacancy tax proposals, and worked to defeat or weaken progressive housing measures at the state and local level.
Source:
https://www.inman.com/2025/12/04/nar-spent-big-on-exec-salaries-marketing-and-lobbying-in-2024/

This lobbying exists alongside a well-documented paradox: the United States has millions of vacant or underused housing units while homelessness continues to rise. Census data estimates between 14 and 16 million vacant homes, while HUD’s 2024 assessment found over 770,000 people homeless on a single night.
Sources:
https://www.census.gov/housing/hvs/
https://www.hud.gov/press/press_releases_media_advisories/HUD_No_24_005

NAR’s agenda does not directly create homelessness, but it helps maintain a system where vacancy, speculation, and high transaction costs coexist with housing insecurity.


PhRMA: Lobbying the Price of Medicine

The Pharmaceutical Research & Manufacturers of America (PhRMA) spent $29,725,000 lobbying in 2025.
Source: https://www.opensecrets.org/orgs/pharmaceutical-research-manufacturers-of-america/summary?id=D000000138

PhRMA represents major drug manufacturers whose revenues depend heavily on U.S. pricing structures, which remain far higher than those in other high-income countries.

What the Money Is For

PhRMA’s lobbying focuses on shaping policy around drug pricing, Medicare and Medicaid reimbursement, patent protections, and competition from generics and biosimilars. When policymakers advance proposals allowing Medicare to negotiate prices or cap costs, industry lobbying intensifies.

Numerous studies show that U.S. drug prices are significantly higher than those paid in peer nations, a gap often attributed to policy choices shaped in part by sustained industry advocacy.
Source:
https://www.healthaffairs.org/doi/10.1377/hlthaff.2021.00496

Critics argue that this lobbying preserves profits at the expense of affordability, while defenders claim it protects long-term research investment. Regardless of framing, the scale of spending ensures pharmaceutical interests remain deeply embedded in health policy decisions.

Woman’s hand pours the medicine pills out of the bottle

American Hospital Association: Lobbying for Institutional Stability

The American Hospital Association (AHA) reported $23,877,784 in lobbying expenditures in 2025.
Source: https://www.opensecrets.org/orgs/american-hospital-assn/summary?id=D000000275

The AHA represents hospitals and health systems navigating rising labor costs, staffing shortages, and reimbursement pressures.

Core Policy Goals

The association lobbies heavily on Medicare and Medicaid payment rates, opposing proposed cuts and supporting extensions of special payment programs for rural and critical-access hospitals. It also engages on workforce policy, immigration rules affecting medical staff, and regulations governing hospital billing and consolidation.

While these efforts are framed as protecting access to care, critics argue that hospital lobbying often resists reforms—such as site-neutral payments or stricter merger oversight—that could reduce costs for patients but lower hospital revenue.
Source:
https://www.healthaffairs.org/content/forefront/hospital-lobbying-and-health-care-costs


Business Roundtable: Coordinated CEO Influence

The Business Roundtable spent $23,570,000 lobbying in 2025.
Source: https://www.opensecrets.org/orgs/business-roundtable/summary?id=D000000095

Unlike trade groups focused on a single sector, Business Roundtable functions as a coordinated voice for CEOs of America’s largest corporations.

What It Pushes For

The organization advocates for lower effective corporate tax rates, lighter regulation, business-friendly trade and immigration policies, and predictable AI and cybersecurity rules. It frames these priorities as pro-growth and pro-investment, but critics argue they disproportionately benefit shareholders and executives.

The Roundtable’s influence comes from coordination. When CEOs act collectively, they present lawmakers with a unified corporate position that is difficult to counterbalance with fragmented public interests.
Source:
https://www.brookings.edu/articles/business-roundtables-influence-on-economic-policy/

Cropped image of business people discussing financial report at meeting

Other Major Lobbying Spenders in 2025

Beyond the top five, many other organizations spent tens of millions shaping federal policy, including:

• Blue Cross/Blue Shield — $20,980,510
• Meta — $19,790,000
• American Medical Association — $18,155,785
• General Motors — $16,540,000
• AARP — $15,560,000
• Amazon.com — $13,985,000
• CTIA — $13,230,000
• America’s Health Insurance Plans — $13,110,000
• Alphabet Inc — $12,255,000
• American Chemistry Council — $12,100,123
• Lockheed Martin — $11,735,105
• Pfizer Inc — $10,880,000
• RTX Corp — $10,660,000
• Pharmaceutical Care Management Association — $10,489,576
• General Dynamics — $9,970,458

Source: https://www.opensecrets.org/federal-lobbying/top-spenders

These figures underscore that concentrated influence is not limited to one sector. It spans healthcare, defense, technology, energy, and finance.


How Average Americans Can Stay Informed and Push Back

The scale of corporate lobbying can feel overwhelming, but influence is not entirely one-directional.

Staying informed begins with transparency tools like OpenSecrets, which allow citizens to see who is funding policy advocacy and where pressure is being applied. Information alone does not change outcomes, but it changes narratives—making it harder to present corporate priorities as neutral or inevitable.

Engaging representatives still matters. Offices track constituent contact, especially when it is sustained and issue-specific. Supporting watchdog organizations, consumer advocacy groups, and labor or community organizations helps counterbalance concentrated interests with organized public pressure.

Voting is part of this equation, but so is attention between elections. Lobbying thrives in low-visibility spaces. Scrutiny raises the cost of influence.

The deeper issue is structural: when shaping national policy requires tens of millions of dollars, participation is inherently unequal. Recognizing that imbalance is the first step toward addressing it—not by assuming lobbying will disappear, but by questioning whose voices dominate and why.


Want to know more about what’s happening in terms of world events? Check out the World Events section of Interconnected Earth.

Leave a Reply

Your email address will not be published. Required fields are marked *

Top